Please select a community
Automation & Microfluidics
Biologics & Bioprocessing
Chemical Process Scale Up
Food & Beverage Analysis
Forensic Science & Clinical Toxicology
Genotyping & Gene Expression
LIMS & ELNs
Metabolomics & Lipidomics
Molecular & Clinical Diagnostics
Next Gen Sequencing
Stem Cells, Cellular Therapy & Biobanking
Become a Member
February 2016 onwards
Submit An Event
Events - October 2012
Indian Lab Automation 2012
30 Oct 2012 - 31 Oct 2012 - Mumbai, India
This conference will amalgamate the cutting-edge techniques used by leading research institutes. With access to all three tracks, Drug Discovery & Development, Advances in Genomics & Informatics and Advances in Bioanalysis, this conference aims to provide delegates with a comprehensive overview of the essential techniques required to investigate current scientific advancements.
The Flow Chemistry workshop will be taking place prior to this conference.
Drug Discovery & Development
In the ever-expanding field of drug development it is vital for scientists to remain at the forefront of drug discovery and refinement in order to keep up with consumerist demand. With a need for improved specificity and fewer side-effects in patients, our speakers will be discussing the sophisticated details of the fundamental techniques required to develop the most successful drugs.
This branch of analytical chemistry is essential in obtaining accurate quantitative measurements of drug metabolites and macromolecules. Keynote presentations will talk about innovative analytical methods, explain their movement towards a more reliable, rational approach of analysis, and describe the considerable impact these techniques can have on the overall success of pharmaceutical research.
Advances in Genomics and Informatics
Despite the remarkable feat of sequencing the human genome nearly ten years ago, the sheer volume of information that DNA provides us with requires continual advancements in the way we unravel and analyse the data. Our speakers will address numerous methods of analysis, particularly focusing on the exciting areas of epigenetics, miRNA and Next-Gen Sequencing.
For more information on the stimulating research involved in epigenetics, miRNA and Next-Gen Sequencing, please view the information on the Genomics Research Asia conference being held later this year.
Promising Class of New Cancer Drugs Cause Memory Loss in Mice
New findings from The Rockefeller University suggest that the original version of BET inhibitors causes molecular changes in mouse neurons, and can lead to memory loss in mice that receive it.
Electrical Control of Cancer Cells
Research led by scientists at The University of Texas Health Science Center at Houston (UTHealth) has revealed a new electrical mechanism that can control these switches.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Inflammation Linked to Colon Cancer Metastasis
A new Arizona State University research study led by Biodesign Institute executive director Raymond DuBois has identified for the first time the details of how inflammation triggers colon cancer cells to spread to other organs, or metastasize.
Structural Discoveries Could Aid in Better Drug Design
Scientists have uncovered the structural details of how some proteins interact to turn two different signals into a single integrated output.
Determining the Age of Fingerprints
Watch the imprint of a tire track in soft mud, and it will slowly blur, the ridges of the pattern gradually flowing into the valleys. Researchers have tested the theory that a similar effect could be used to give forensic scientists a way to date fingerprints.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
Researchers Publish Landmark “Basket Study”
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer originated.
Advertise On This Site
Terms & Conditions
©2015 Technology Networks
, all rights reserved.
Latest presentations and webinars
2,500+ scientific and medical posters
3,700+ scientific videos
JOIN TECHNOLOGY NETWORKS PREMIUM FREE!